|
ESR1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.964610E-04 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.194800E-04 |
| Normal-vs-Stage2 |
1.638350E-04 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.954940E-04 |
| Stage1-vs-Stage2 |
2.656400E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
5.729200E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
5.532000E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.956130E-04 |
| Normal-vs-AfricanAmerican |
9.183200E-03 |
| Normal-vs-Asian |
2.719300E-03 |
| Caucasian-vs-AfricanAmerican |
9.965600E-01 |
| Caucasian-vs-Asian |
5.527000E-01 |
| AfricanAmerican-vs-Asian |
6.958200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.177700E-04 |
| Normal-vs-Female |
1.824520E-04 |
| Male-vs-Female |
3.139000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.446850E-04 |
| Normal-vs-Extreme_Weight |
1.619930E-04 |
| Normal-vs-Obese |
2.574500E-04 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
2.981200E-01 |
| Normal_Weight-vs-Obese |
9.091800E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
1.385960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.219300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.845450E-04 |
| Normal-vs-Age(61-80Yrs) |
2.182100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.577330E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.273400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.886400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.181000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.714800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.520800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.366200E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
4.351000E-01 |
| Normal-vs-Grade 3 |
7.867000E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
5.768400E-01 |
| Grade 2-vs-Grade 4 |
4.351000E-01 |
| Grade 3-vs-Grade 4 |
7.867000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.76449999999396E-05 |
| Normal-vs-N1 |
5.88719999999876E-05 |
| N0-vs-N1 |
8.559000E-01 |
|
|
